Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Align Tech ( (ALGN) ) has shared an update.
On May 1, 2026, Align Technology announced plans to repurchase $200 million of its common stock via open market transactions under a previously authorized $1 billion buyback program. Management framed the move as a signal of confidence in the firm’s long-term growth strategy and balance-sheet strength, highlighting its ability to generate strong cash flow while continuing to invest in key strategic initiatives.
The repurchases will be executed under a Rule 10b5-1 trading plan, with timing and volume dependent on market conditions, including share price, trading activity, broader business environment, and capital availability. The program is expected to be completed by October 2026 and funded from cash on hand, with Align reporting $1.06 billion in cash and cash equivalents and about 71.6 million shares outstanding as of March 31, 2026.
The most recent analyst rating on (ALGN) stock is a Hold with a $186.00 price target. To see the full list of analyst forecasts on Align Tech stock, see the ALGN Stock Forecast page.
Spark’s Take on ALGN Stock
According to Spark, TipRanks’ AI Analyst, ALGN is a Outperform.
ALGN scores well on fundamentals, led by a very strong balance sheet and solid profitability/cash generation, but tempered by multi-year margin compression and uneven free-cash-flow consistency. The latest earnings call was broadly positive with reaffirmed guidance and margin improvement, while the stock’s technical picture is neutral and valuation remains relatively rich with no dividend support.
To see Spark’s full report on ALGN stock, click here.
More about Align Tech
Align Technology, Inc. is a global medical device company specializing in digital orthodontics and restorative dentistry. It designs and manufactures the Invisalign clear aligner system, iTero intraoral scanners and services, and exocad CAD/CAM software, serving roughly 299,500 doctor customers and targeting a 600 million consumer market worldwide.
Over 29 years, Align has helped doctors treat about 22.8 million patients with Invisalign and is advancing digital dentistry through its integrated Align Digital Platform. The company positions its technologies as end-to-end solutions for patients, orthodontists, general practitioner dentists, and laboratory partners, aiming to boost clinical outcomes and practice efficiency.
Average Trading Volume: 1,315,281
Technical Sentiment Signal: Sell
Current Market Cap: $12.61B
For detailed information about ALGN stock, go to TipRanks’ Stock Analysis page.